Results 1 to 10 of about 1,947 (140)

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection [PDF]

open access: yesBMC Microbiology, 2011
Background Interest in phage therapy has grown over the past decade due to the rapid emergence of antibiotic resistance in bacterial pathogens. However, the use of bacteriophages for therapeutic purposes has raised concerns over the potential for immune ...
Kempashanaiah Nanjundappa   +7 more
doaj   +4 more sources

Modulation of Endolysin LysECD7 Bactericidal Activity by Different Peptide Tag Fusion

open access: yesBiomolecules, 2020
The use of recombinant endolysins is a promising approach for antimicrobial therapy capable of counteracting the spread of antibiotic-resistant strains.
Nataliia P. Antonova   +16 more
doaj   +3 more sources

Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2018
Objective(s): Phage therapy is a potential alternative treatment for infections caused by Acinetobacter baumannii, a significant nosocomial pathogen, which has evolved resistance to almost all conventional antimicrobial drugs in poor hygiene and ...
Hayder Nsaif Jasim   +2 more
doaj   +1 more source

Phage Endolysins: Advances in the World of Food Safety

open access: yesCells, 2023
As antimicrobial resistance continues to escalate, the exploration of alternative approaches to safeguard food safety becomes more crucial than ever. Phage endolysins are enzymes derived from phages that possess the ability to break down bacterial cell ...
Amina Nazir   +3 more
doaj   +1 more source

2.PHAGE COCKTAILS AGAINST HIGHLY MULTI-DRUG RESISTANT ACINETOBACTER BAUMANII

open access: yesThe Iraqi Journal of Medical Sciences, 2019
Background:Phage therapy is a potential alternative treatment for infections caused by many bacterial species such as Acinetobacter baumannii (A.
Hayder N. Jasim, Ahmad S. Abdul-Ameer
doaj   +6 more sources

Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy [PDF]

open access: yes, 2018
Peptidoglycan degrading enzymes are of increasing interest as antibacterial agents, especially against multi-drug resistant pathogens. Herein we present a review about the biological features of virion-associated lysins and endolysins, phage-derived ...
Azeredo, Joana   +2 more
core   +2 more sources

PHAGE COCKTAILS AGAINST HIGHLY MULTI-DRUG RESISTANT ACINETOBACTER BAUMANII

open access: yesThe Iraqi Journal of Medical Sciences, 2018
Background:Phage therapy is a potential alternative treatment for infections caused by many bacterial species such as Acinetobacter baumannii (A.
Hayder Jasim, Ahmad Abdul-Ameer
doaj   +1 more source

Engineered endolysin-based "artilysins" to combat multidrug-resistant gram-negative pathogens [PDF]

open access: yes, 2014
The global threat to public health posed by emerging multidrug-resistant bacteria in the past few years necessitates the development of novel approaches to combat bacterial infections.
Brenner   +40 more
core   +4 more sources

Prophage-triggered membrane vesicle formation through peptidoglycan damage in Bacillus subtilis [PDF]

open access: yes, 2017
Bacteria release membrane vesicles (MVs) that play important roles in various biological processes. However, the mechanisms of MV formation in Gram-positive bacteria are unclear, as these cells possess a single cytoplasmic membrane that is surrounded by ...
Cárcamo-Oyarce Gerardo   +11 more
core   +1 more source

Structure and activity of ChiX, a peptidoglycan hydrolase required for chitinase secretion by Serratia marcescens [PDF]

open access: yes, 2018
The Gram‐negative bacterium Serratia marcescens secretes a number of proteins that are involved in extracellular chitin degradation. This so‐called chitinolytic machinery includes three types of chitinase enzymes and a lytic polysaccharide monooxygenase.
Adam Lodge   +48 more
core   +2 more sources

Home - About - Disclaimer - Privacy